Surghive raises six-figure seed for cross-platform robotic surgery training
What's the deal? Surghive, a Teesside-based robotic surgery training startup, has raised an undisclosed six-figure seed round from SFC CapitalDealroom has a profile for this one. Try Dealroom → and the Chadda family. The money will fund development of manufacturer-independent immersive training software for surgeons and operating-theatre teams.
What's the endgame? The company is building training that works across robotic platforms, rather than being tied to a single manufacturer's system. The aim is to let surgeons and surgical teams practise skills regardless of the robot they use.
Why now? Robotic surgery is expanding fast, but training remains a bottleneck. The American College of Surgeons has flagged the need to train not just surgeons but nurses, anesthesiologists, and operating-room teams, while cost and infrastructure limit adoption.
Surghive was founded by Dr Rachael Coates, a robotic colorectal surgeon and chief executive; Christi Anderson, chief operating and financial officer and a former PwCDealroom has a profile for this one. Try Dealroom → director; and Professor Deena Harji, consultant colorectal surgeon and chief medical officer. Andy Wood, former executive chairman of Cubic Motion — acquired by Epic Games in 2020 — joined as non-executive chairman in October.
What they're saying: "As robotic surgery becomes increasingly established, there is a clear need for training solutions that can develop alongside the technology and be delivered at scale," said Ed Stevenson, fund principal at SFC Capital.
Shkun Chadda, a science and technology investor, said the firm was drawn to Surghive because "it is solving a real problem and isn't technology for technology's sake." He added: "At this stage of a company's journey, you are investing in people as much as you are investing in technology."
The raise follows a £40,000 Innovation Voucher from the Tees Valley Investment Zone in September, supporting an app layer that connects surgeons with learning, competency requirements, and personalised recommendations.
What could go wrong? The platform is still in development. Its significance will depend on proving the software works across systems and can be adopted at scale, as the company builds evidence and customer relationships.
The signal: A shift toward multi-vendor robotic systems is pushing demand for generic, standardised training as the market diversifies. Surghive's bet is that manufacturer-independent software fills a real adoption gap — if it can show results across platforms.
Read more: businessupnorth.co.uk
Image credit: Generated with Gemini
